Esophageal Neoplasms  >>  oxaliplatin  >>  Phase 1
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00003427: Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer

Completed
1
36
US
irinotecan hydrochloride, oxaliplatin
Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI)
Anal Cancer, Colorectal Cancer, Esophageal Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer, Gastrointestinal Carcinoid Tumor, Liver Cancer, Pancreatic Cancer, Small Intestine Cancer
04/02
04/02
NCT00004257: Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer

Completed
1
US
fluorouracil, oxaliplatin, conventional surgery, radiation therapy
Albany Medical College, National Cancer Institute (NCI)
Esophageal Cancer
 
01/04
NCT01561014: Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Completed
1
9
US
erlotinib hydrochloride, CP-358,774, erlotinib, OSI-774, oxaliplatin, 1-OHP, Dacotin, Dacplat, Eloxatin, L-OHP, fluorouracil, 5-fluorouracil, 5-Fluracil, 5-FU, radiation therapy, irradiation, radiotherapy, therapy, radiation, conventional surgery, surgery, conventional, immunohistochemistry staining method, immunohistochemistry, positron emission tomography, FDG-PET, PET, PET scan, tomography, emission computed, computed tomography, tomography, computed, laboratory biomarker analysis, gene expression analysis, fludeoxyglucose F 18, 18FDG, FDG
Wake Forest University Health Sciences, National Cancer Institute (NCI)
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Squamous Cell Carcinoma of the Esophagus, Stage II Esophageal Cancer, Stage II Gastric Cancer, Stage III Esophageal Cancer, Stage III Gastric Cancer
03/09
03/09
VEOX, NCT01386346: Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer

Completed
1
12
US
Azacitidine, Vidaza®, 5-Azacitidine, Oxaliplatin, Eloxatin, Epirubicin, Ellence, Capecitabine, Xeolda
Weill Medical College of Cornell University, Celgene Corporation
Esophageal Cancer, Malignant Neoplasm of Cardio-esophageal Junction of Stomach
08/14
09/18
PIFA, NCT01719926: Phase I Platinum Based Chemotherapy Plus Indomethacin

Completed
1
13
Europe
Indomethacin
UMC Utrecht
Colorectal Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms
08/17
08/17

Download Options